BPC-157 in Australia

BPC-157 is one of the most widely studied compounds in tissue-repair research, and one of the most frequently searched-for research peptides in Australia. This page covers what it is, the research areas it appears in, and how to source it with proper documentation from local stock.

What is BPC-157?

BPC-157 is a synthetic peptide made up of 15 amino acids (a "pentadecapeptide"), based on a partial sequence of a protein found in gastric juice. It's stable, well-characterised, and one of the most-referenced peptides in cell and tissue-repair research literature.

The name is an abbreviation of "Body Protection Compound", and the sequence is derived from a larger protein isolated from gastric juice — BPC-157 represents a fragment of that parent sequence rather than the whole molecule. It carries no fatty-acid modification and no unusual residues; it is a comparatively simple, short, unmodified chain, which is part of why it is inexpensive to synthesise and why so much laboratory work has been done with it.

Its most-cited property in the literature is stability. Short peptides are usually degraded quickly in biological media, but BPC-157 is repeatedly described as resistant to breakdown in gastric-juice conditions — unusual enough that it is one of the compound's defining characteristics in published work, and a large part of why it appears in so many experimental models.

Research areas

In the scientific literature, BPC-157 is studied in relation to:

• Muscle, tendon and ligament repair research
• Gut-lining and digestive-tract research models
• Angiogenesis (blood-vessel formation) research
• Inflammation and recovery-pathway research
• Growth-factor and VEGF-pathway signalling research
• Connective-tissue and fibroblast research models

These describe fields of scientific study — they are not claims about effects in humans. Nothing on this page should be read as a statement about what the compound does in a person, and NextGen Peptides supplies it strictly for laboratory and in-vitro research use.

The angiogenesis work is worth singling out, because it is the thread connecting most of the others. A significant portion of the published literature examines BPC-157 in relation to blood-vessel formation and growth-factor signalling pathways, and tissue-repair models frequently return to that mechanism as the point of interest. It is the reason the compound appears across such apparently different research areas — musculoskeletal, gastrointestinal and vascular models are often investigating the same underlying pathway.

BPC-157 and TB-500 in comparative research

These two compounds are the most-referenced pair in the tissue-repair category, and they are frequently studied side by side because they are mechanistically distinct rather than interchangeable.

• BPC-157 is a 15-amino-acid fragment of a gastric protein, most associated in the literature with angiogenesis and growth-factor signalling pathways.
• TB-500 is a synthetic fragment of thymosin beta-4, most associated with actin regulation and cell-migration pathways.

Different mechanism, overlapping research areas — which is precisely why comparative studies exist. Our BPC-157 vs TB-500 guide works through the structural and pathway differences in full.

Storage & handling

Supplied as a lyophilised (freeze-dried) powder. Store at −20°C; reconstitute with bacteriostatic water and refrigerate once mixed. See our full guide to storing and reconstituting research peptides.

The points that determine whether a vial survives its working life:

• Before reconstitution. Lyophilised powder is stable and forgiving. At −20°C and out of light it keeps long-term, and it tolerates refrigeration and short periods at room temperature in transit — which is why vials ship without cold chain and arrive intact.
• Choice of diluent. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which is what allows a vial to be drawn from repeatedly over weeks. Sterile water has no preservative and is single-use.
• Technique. Run the diluent slowly down the inside wall of the vial rather than onto the powder cake, then swirl gently until dissolved — never shake. Foaming is the visible sign the molecule is being mechanically denatured.
• After reconstitution. Refrigerate at 2–8°C, generally good for around four weeks. Never refreeze — ice crystals forming through a freeze–thaw cycle physically damage peptide structure.
• Steady beats convenient. Keep vials boxed and towards the back of the fridge, not the door. Repeated warming and cooling does more damage than one stable temperature.

Concentration is set by how much diluent you add, not by the vial itself — a 10mg vial reconstituted with 1mL gives 10mg/mL, and with 2mL gives 5mg/mL. Our peptide reconstitution calculator works out the resulting concentration and draw volume for any combination.

What the Certificate of Analysis tells you

A Certificate of Analysis is the only objective evidence that what is in the vial matches the label. Two tests carry the weight:

• RP-HPLC establishes purity — it separates the sample into components and reports the target peptide as a percentage of the total. Research-grade material is typically ≥98%.
• LC-MS establishes identity — it measures molecular mass and confirms the compound is the peptide named on the label, not a different molecule of similar purity.

Purity alone is not sufficient: a highly pure sample of the wrong compound still returns an excellent HPLC figure. A complete certificate also carries a batch number you can match against the vial in your hand, plus a test date. Certificates are published in our CoA library; our guide to reading a peptide CoA walks through a real one line by line, and how peptide purity is tested covers the methods themselves.

Sourcing BPC-157 in Australia

We hold BPC-157 in Australian stock, so orders placed before the daily cut-off are dispatched same or next business day — no overseas freight, no customs wait. Every batch is independently third-party tested for purity (RP-HPLC) and identity (LC-MS), and the Certificate of Analysis is published for you to read before you order. Available as a single 10MG vial or a discounted 10-vial pack.

Local stock changes the practical picture. Orders of research chemicals shipped into Australia from overseas carry a real risk of being held or refused at the border, and even when they clear, two-to-four-week transit is normal — with the material outside controlled storage for that entire period. Domestic dispatch removes both problems: orders leave Melbourne, arrive inside the normal domestic post window, and are tracked the whole way in discreet, unmarked packaging. Full terms are on our shipping page.

When comparing suppliers the questions stay the same: is there a published CoA, does its batch number match the vial, does it cover identity as well as purity, and is the stock genuinely held in Australia rather than drop-shipped from overseas after you pay? Our guide to buying research peptides in Australia covers what to check. Laboratories and clinics ordering at volume can see wholesale and bulk supply.

Common questions about BPC-157

What is BPC-157?
A synthetic 15-amino-acid peptide (a pentadecapeptide) based on a partial sequence of a protein found in gastric juice — one of the most-studied compounds in tissue-repair research. Supplied for laboratory research use only.

What research areas is BPC-157 studied in?
Muscle, tendon and ligament repair research, gut-lining research, angiogenesis (blood-vessel formation), and inflammation and recovery pathways. These are fields of study, not effects in humans.

Is BPC-157 tested, and does it come with a CoA?
Yes — every batch is independently third-party tested for purity (RP-HPLC) and identity (LC-MS), with the Certificate of Analysis published to read before you order.

How should BPC-157 be stored?
As a lyophilised powder, store at −20°C. Once reconstituted with bacteriostatic water, refrigerate and use within the stated window.

Is BPC-157 held in Australian stock?
Yes — held locally and dispatched same or next business day for orders placed before the daily cut-off.

What does BPC-157 stand for?
"Body Protection Compound". The sequence is a 15-amino-acid fragment derived from a larger protein isolated from gastric juice, rather than the full parent molecule.

How is BPC-157 different from TB-500?
They are mechanistically distinct. BPC-157 is a gastric-protein fragment most associated in the literature with angiogenesis and growth-factor signalling; TB-500 is a thymosin beta-4 fragment most associated with actin regulation and cell migration. See our full comparison.

How long does a reconstituted vial last?
Generally around four weeks refrigerated at 2–8°C when reconstituted with bacteriostatic water. Unreconstituted powder at −20°C keeps far longer. Never refreeze a reconstituted solution.

What should I reconstitute it with?
Bacteriostatic water for multi-draw use — the 0.9% benzyl alcohol preservative is what makes repeated draws viable. Sterile water is single-use. Our reconstitution calculator works out the resulting concentration.

Why doesn't purity testing prove identity?
Because RP-HPLC measures how much of the sample is a single component, not which component it is. A pure sample of the wrong peptide still returns a high purity figure. LC-MS confirms molecular mass and therefore identity — a complete certificate has both.

Does it need cold-chain shipping?
No. Lyophilised powder is stable in transit. Orders ship from Melbourne in discreet, unmarked packaging with tracking — see shipping & delivery.

Legal status and intended use

BPC-157 is supplied by NextGen Peptides strictly as a research chemical for laboratory and in-vitro use. It is not an approved therapeutic good in Australia, it is not supplied for human or veterinary consumption, and nothing on this site constitutes medical advice. Purchasers must be 18 or over.

The regulatory position around research peptides in Australia is worth understanding before ordering rather than assuming. We set out the framework — how the Therapeutic Goods Act treats unapproved goods, and where research-use supply sits within it — in our guide to the legal status of research peptides in Australia.

Related research

Explore related compounds held in Australian stock: TB-500 and KPV.

Further reading: BPC-157 vs TB-500.

Shop BPC-157

Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary consumption. The research areas listed describe fields of scientific study, not claims about effects in humans, and nothing here is medical advice.